Healthcare Realty Trust vs Sabra Health Care REIT
HR and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HR and SBRA compare
Healthcare Realty Trust is the larger company, worth 1.3 times as much as Sabra Health Care REIT ($6.5B against $5.2B).
Sabra Health Care REIT grew revenue faster over the last twelve months (17.3% versus −5.8% for Healthcare Realty Trust).
Sabra Health Care REIT keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with −4.0% at Healthcare Realty Trust.
Both pay dividends: Healthcare Realty Trust yields 3.7% and Sabra Health Care REIT 7.4%.
Sabra Health Care REIT scores higher on the StockData Score (6 against 3 for Healthcare Realty Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HR | SBRA |
|---|---|---|
| Size and price | ||
| Market cap | $6.5B | $5.2B |
| Share price | $19.32 | $20.35 |
| Change, 1 year | 6.0% | 8.9% |
| Change, 5 years | −40.8% | 54.0% |
| Beta (5Y) | – | −0.09 |
| Employees | 539 | 58 |
| StockData Score | ||
| Total score | 3 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 0 | 0 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | – | 78.3× |
| P/S | 5.8× (better) | 6.0× |
| P/B | 1.6× (better) | 1.9× |
| EV/EBITDA | – | 12.9× |
| Fair value | $14.53 | $12.79 |
| Margin of safety | −33.0% (better) | −59.1% |
| Growth | ||
| Revenue growth (TTM) | −5.8% | 17.3% (better) |
| Revenue growth, 5Y average | 18.8% (better) | 5.3% |
| Net income growth (TTM) | – | −64.1% |
| EPS growth (TTM) | – | −65.8% |
| EPS growth, 5Y average | – | −0.91% |
| Profitability | ||
| Net margin | −4.0% | 7.6% (better) |
| Return on equity | −1.0% | 2.4% (better) |
| Financial health | ||
| Altman Z-score | 0.94 | 1.29 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 3.7% | 7.4% (better) |
| Payout ratio | – | 455% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −1.7% (better) | −2.3% |
| Buyback yield | 0.05% | – |
| Shareholder yield | 3.8% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 112% | 102% |
| Held by insiders | 5.0% | 1.9% |
| Insider net buying, 12 months | −$745K (better) | −$4.7M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.3% | 7.1% |
Go deeper
- HR stock overview
- HR income statement
- HR valuation and score
- SBRA stock overview
- SBRA income statement
- SBRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.